A meta-analysis of randomized controlled trials presented at the American College of Cardiology’s Annual Scientific Session suggests RNA therapeutics reduce mortality and cardiac failure risk in...
A prespecified analysis of the HELIOS-B trial evaluates how vutrisiran affects individual components of quality of life in transthyretin cardiomyopathy, offering clinically relevant insights for cardiology...
A systematic review and meta-analysis presented at the 2026 American College of Cardiology Scientific Session evaluated whether tafamidis was associated with improved survival in patients aged 80 years and...
A recent study explored blood pressure reduction in midlife men and women. Which group showed the greatest improvement? Test your knowledge in our quiz!
In her American College of Cardiology 2025 presentation, “Arrhythmias in Athletes: Management and Return to Play,” Rachel Lampert, MD, Robert W. Berliner Professor of Medicine at the Yale School of...
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
In this interview, Ana Ormaza Vera, MD, discusses findings from a study she presented at the American College of Cardiology’s 74th Annual Scientific Session & Expo on March 29, 2025, in Chicago. She...
Jayne Morgan, MD discusses a study on blood pressure reduction in midlife women using the Hello Heart mobile health system and its impact on heart health. This study will be presented at the American...